AU6315300A - Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same - Google Patents

Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same

Info

Publication number
AU6315300A
AU6315300A AU63153/00A AU6315300A AU6315300A AU 6315300 A AU6315300 A AU 6315300A AU 63153/00 A AU63153/00 A AU 63153/00A AU 6315300 A AU6315300 A AU 6315300A AU 6315300 A AU6315300 A AU 6315300A
Authority
AU
Australia
Prior art keywords
sensitivity
drug
same
agents containing
benzene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63153/00A
Inventor
Akira Ino
Moriyasu Masui
Kazuo Ueda
Ken Yasui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU6315300A publication Critical patent/AU6315300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU63153/00A 1999-07-26 2000-07-26 Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same Abandoned AU6315300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21139999 1999-07-26
JP11/211399 1999-07-26
PCT/JP2000/005001 WO2001007031A1 (en) 1999-07-26 2000-07-26 Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same

Publications (1)

Publication Number Publication Date
AU6315300A true AU6315300A (en) 2001-02-13

Family

ID=16605334

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63153/00A Abandoned AU6315300A (en) 1999-07-26 2000-07-26 Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same

Country Status (2)

Country Link
AU (1) AU6315300A (en)
WO (1) WO2001007031A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1416028A1 (en) * 2002-10-30 2004-05-06 Covion Organic Semiconductors GmbH New method for the production of monomers useful in the manufacture of semiconductive polymers
EP1894917B1 (en) 2003-12-22 2010-01-20 Basilea Pharmaceutica AG Aryloxy- and arylthioxyacetophenone-type compounds for the treatment of cancer
KR101233223B1 (en) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 Liquid crystal compound having a chroman ring, liquid crystal composition, and liquid crystal display device comprising the liquid crystal composition
WO2008154484A1 (en) 2007-06-08 2008-12-18 Mannkind Corporation Ire-1a inhibitors
CA2738328A1 (en) * 2008-08-29 2010-03-04 Novogen Research Pty Ltd Immunomodulating activities
EP2953938B1 (en) 2014-02-07 2017-08-02 Novogen Ltd. Functionalised benzopyran compounds and use thereof
HUE054998T2 (en) 2015-02-02 2021-10-28 Mei Pharma Inc Combination therapies for use in the treatment of breast cancer

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558667A (en) * 1968-11-01 1971-01-26 Sterling Drug Inc Benzofurans from o-phenyl ketoximes
JPS58110557A (en) * 1981-12-25 1983-07-01 Kanagawa Kagaku Kenkyusho:Kk Urea derivative
JPS59108775A (en) * 1982-12-14 1984-06-23 Ube Ind Ltd Preparation of benzofuranol
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
US4704462A (en) * 1985-08-22 1987-11-03 Merck & Co., Inc. Substituted 2,3,3a,6-tetrahydro-6-oxobenzofuran derivative useful as PAF antagonist
DE3674521D1 (en) * 1985-08-29 1990-10-31 Hoechst Ag 6-PHENOXYMETHYL-4-HYDROXYTETRAHYDROPYRAN-2-ONE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINAL PRODUCTS, PHARMACEUTICAL PREPARATIONS AND INTERMEDIATE PRODUCTS.
US4837235A (en) * 1985-10-17 1989-06-06 Ici Americas Inc. Indole and indazole keto sulphones as leukotriene antagonists
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
JPS62138487A (en) * 1985-12-13 1987-06-22 Mitsui Petrochem Ind Ltd Production of 2,3-dihydrobenzofuran
JP2566771B2 (en) * 1987-03-09 1996-12-25 丸善製薬株式会社 2- (2,4-dihydroxyphenyl) -4-methoxy-5- (3-methyl-2-butenyl) -6-hydroxycoumarone and preservative
DE3903988A1 (en) * 1989-02-10 1990-08-30 Basf Ag OXIDIZED DIPHENYLHETEROALKANES, THEIR PREPARATION AND USE
US4994486A (en) * 1989-05-31 1991-02-19 Abbott Laboratories Dopaminergic compounds
JPH0368515A (en) * 1989-08-08 1991-03-25 Tsumura & Co Antiallergic drug
JPH04166040A (en) * 1990-05-16 1992-06-11 Maruzen Kasei Co Ltd Feed additive for fish farming and feed for fish framing
DE4117512A1 (en) * 1991-05-25 1992-11-26 Schering Ag 2-PHENYLBENZO (B) FURANES AND THIOPHENES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JPH05139946A (en) * 1991-11-19 1993-06-08 Kao Corp Melanin inhibitor
JP3592342B2 (en) * 1991-12-27 2004-11-24 株式会社リコー Electrophotographic photoreceptor
JP3191176B2 (en) * 1992-07-01 2001-07-23 ソニーケミカル株式会社 Adhesive composition
EP0581095A2 (en) * 1992-07-24 1994-02-02 BASF Aktiengesellschaft Substituted acrylic acid esters and plant-protecting agents containing them
JP2629166B2 (en) * 1993-06-17 1997-07-09 日本製紙株式会社 Antibacterial agent effective against methicillin-resistant Staphylococcus aureus
JPH07118255A (en) * 1993-10-26 1995-05-09 Canon Inc Optically active compound, liquid crystal composition containing the same, liquid crystal element having the same composition, display device using the same element and display method using the same composition
JPH07179856A (en) * 1993-12-21 1995-07-18 Canon Inc Liquid crystal compound, liquid crystal composition containing this compound, liquid crystal element containing this composition, and method and device for display therewith
JPH08157463A (en) * 1994-11-30 1996-06-18 Canon Inc Liquid crystal compound, liquid crystal composition containing the same, liquid crystal element having the same and display or liquid crystal unit using the same
JPH08268858A (en) * 1995-04-03 1996-10-15 Shiseido Co Ltd Skin preparation for external use
EP0767170B1 (en) * 1995-04-13 2002-10-23 Taiho Pharmaceutical Co., Ltd. Novel 4,6-diarylpyrimidine derivatives and salts thereof
ES2258775T3 (en) * 1995-05-19 2006-09-01 Kyowa Hakko Kogyo Co., Ltd. HETEROCICLICAL COMPOUNDS CONTAINING OXYGEN.
JPH09124632A (en) * 1995-10-31 1997-05-13 Sankyo Co Ltd Benzo-heterocyclic derivative
DE69713582T2 (en) * 1996-03-29 2003-01-09 Searle & Co Cinnamic acid derivatives and their use as integrin antagonists
DE19615263A1 (en) * 1996-04-18 1997-10-23 Bayer Ag Benzyloxy substituted phenylglycinolamides
JPH107555A (en) * 1996-06-17 1998-01-13 Oji Paper Co Ltd Antimicrobial agent
IT1284971B1 (en) * 1996-10-17 1998-05-28 Indena Spa PHARMACEUTICAL AND COSMETIC FORMULATIONS WITH ANTI-ACNE ACTIVITIES
JPH10204059A (en) * 1997-01-22 1998-08-04 Ono Pharmaceut Co Ltd Phenylsulfonamide derivative
JPH1135557A (en) * 1997-07-17 1999-02-09 Ono Pharmaceut Co Ltd Phenylsulfonamide derivative
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
EP1057825A4 (en) * 1998-01-27 2001-10-24 Shionogi & Co Isoflavane derivatives and immunopotentiating compositions containing the same

Also Published As

Publication number Publication date
WO2001007031A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
AU5636498A (en) Pesticide composition
AU1933500A (en) Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU3898900A (en) Redundancy elimination in the persistence of object graphs
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0001154A3 (en) 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
AU5972598A (en) Pesticide compositions
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
AU6408898A (en) Antimicrobial compositions, their preparation and use
AU7651100A (en) Pharmaceutical and/or cosmetical compositions
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
AU4583599A (en) Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto
AU2841801A (en) Triazolotriazinones and the use thereof
AU2579797A (en) Antimicrobial agent
AU7053798A (en) Synergetic fungicide composition
AU6315300A (en) Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
AU1152601A (en) Compositions and their use
AU6229099A (en) Dihydropyridine derivatives and drug compositions containing the same
IL136045A0 (en) Pyridylpyrrole derivatives and pharmaceutical compositions containing the same
AU2183899A (en) Isoflavane derivatives and immunopotentiating compositions containing the same
AU6016000A (en) Tricyclic compounds and drug compositions containing the same
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
AU8035698A (en) Substituted lower alkanesulfonamide derivatives and pharmaceutical composition containing the same
AU2001241117A1 (en) Fused-benzoyl derivatives and herbicide compositions containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase